LOMBARDI, GAETANO
 Distribuzione geografica
Continente #
AS - Asia 232
NA - Nord America 214
EU - Europa 181
Continente sconosciuto - Info sul continente non disponibili 1
Totale 628
Nazione #
US - Stati Uniti d'America 207
CN - Cina 87
HK - Hong Kong 79
IT - Italia 65
SE - Svezia 57
SG - Singapore 56
RU - Federazione Russa 14
FI - Finlandia 7
IE - Irlanda 7
CA - Canada 5
DE - Germania 5
NL - Olanda 5
GB - Regno Unito 4
PH - Filippine 4
DK - Danimarca 3
IN - India 3
LT - Lituania 3
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
FR - Francia 2
MX - Messico 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
EE - Estonia 1
EU - Europa 1
SA - Arabia Saudita 1
Totale 628
Città #
Hong Kong 79
Shanghai 56
Singapore 45
Ashburn 36
New York 34
Milan 21
Lawrence 13
Princeton 13
Washington 12
Santa Clara 9
Boardman 8
Dublin 7
Helsinki 7
Rome 7
Dallas 6
Brescia 4
Moscow 4
Quezon City 4
Toronto 4
Verona 4
Amsterdam 3
Malo 3
Vittoria 3
Beijing 2
Bengaluru 2
Borås 2
Brno 2
Brussels 2
Cham 2
Gothenburg 2
Guangzhou 2
Gustavo Adolfo Madero 2
Los Angeles 2
Messina 2
Seattle 2
Sestri Levante 2
Shenzhen 2
Taipei 2
Buffalo 1
Council Bluffs 1
Coventry 1
Fermo 1
Graham 1
Guiyang 1
Handan 1
Jianning 1
Jiaxing 1
Jingmen 1
Laurel 1
London 1
Lucca 1
Luoyang 1
Macerata 1
Miami 1
Munich 1
Naaldwijk 1
Nantong 1
Newark 1
Nuremberg 1
Ottawa 1
Padova 1
Pune 1
Riyadh 1
Santa Lucia Di Piave 1
Secaucus 1
Segrate 1
Shenyang 1
Shijiazhuang 1
Tallinn 1
Tirana 1
Trumbull 1
Turin 1
Villimpenta 1
Zhengzhou 1
Totale 448
Nome #
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 48
Four Decades of Randomized Clinical Trials Influencing Mortality in Critically Ill and Perioperative Patients 42
Effects on health-related quality of life of interventions affecting survival in critically ill patients: a systematic review 40
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 37
Procedural sedation and analgesia for percutaneous high-tech cardiac procedures 37
Home ventilators for invasive ventilation of patients with COVID-19 36
Trigger and Target for Fibrinogen Supplementation Using Thromboelastometry (ROTEM) in Patients Undergoing Open Thoraco-Abdominal Aortic Aneurysm Repair 36
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 35
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 33
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 30
Gender-gap in randomized clinical trials reporting mortality in the perioperative setting and critical care: 20 years behind the scenes 29
Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study 27
Percutaneous tracheostomy in COVID-19 patients: a new apneic approach 27
Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: A case series 27
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials 22
Long-term quality of life after intensive care unit admission (A single-center observational study) 20
Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel 18
Feasibility, safety and efficacy of COVID-19 severe acute respiratory distress syndrome management without invasive mechanical ventilation 17
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w) 13
Medical Information Extraction With NLP-Powered QABots: A Real-World Scenario 9
Genetics of Inflammatory Bowel Disease 7
HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder 7
HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: A critical reappraisal with review of the literature 7
Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: Comparison of different assays and correlation with clinical features 7
Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: A GISC study 7
Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: Clinical role and review of the literature 7
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: A single-blind randomized controlled trial 7
Contribution of IBD5 locus to clinical features of IBD patients 6
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia 6
Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study 6
ERCP complications: Risk factors and prophylaxis 6
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis 6
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus 6
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - A GISC study 5
Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients - A pilot uncontrolled study 5
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - An IG-IBD study 5
Use of botulinum toxin in esophageal achalasia 4
Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis 4
NOD2/CARD15 in healthy relatives of IBD paients 4
The IBD International Genetics Consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction 3
Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation 1
Remote ischemic preconditioning in non-cardiac surgery (PRINCE): a multinational, double blind, sham-controlled, randomized clinical trial 1
Totale 700
Categoria #
all - tutte 6.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 1 1
2020/202111 0 0 1 1 0 4 1 0 2 0 1 1
2021/202233 2 0 0 4 3 2 2 5 1 3 6 5
2022/2023132 32 25 13 4 14 11 8 10 1 1 4 9
2023/2024211 4 4 34 21 22 56 3 21 0 3 11 32
2024/2025311 24 17 11 50 56 72 81 0 0 0 0 0
Totale 700